NCT02727959View on ClinicalTrials.gov

Inflammatory Bowel Disease in South Eastern Norway

CompletedOBSERVATIONAL
Enrollment

2,286

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Colitis, UlcerativeCrohn DiseaseInflammatory Bowel Disease
Trial Locations (1)

0871

Oslo University Hospital, Oslo

Sponsors
All Listed Sponsors
collaborator

University of Oslo

OTHER

collaborator

Oslo Metropolitan University

OTHER

collaborator

Takeda

INDUSTRY

collaborator

Ferring Pharmaceuticals

INDUSTRY

lead

Oslo University Hospital

OTHER